Industry News
-
Sensorion Advances AAV Gene Therapy Pipeline in Genetic Hearing Loss
Mar 19 2026 -
Sarepta Therapeutics Advances AAV Gene Therapy Safety Strategy in Duchenne Trial
Mar 18 2026 -
Innorna Secures FDA Clearance for Phase 1 mRNA Therapy in Refractory Gout
Mar 17 2026 -
Norway Recommends Reimbursement of AAV Gene Therapy for Haemophilia B
Mar 17 2026 -
AAV8 Gene Therapy GS001 Shows Durable FVIII Expression in Hemophilia A at Lower Doses
Mar 13 2026 -
Cbio Receives Regulatory Clearance to Launch First-in-Human Trial of T-Cell Therapy
Mar 13 2026 -
Solid Biosciences Reports Encouraging Early Data for AAV Gene Therapy SGT-003 in Duchenne Muscular Dystrophy
Mar 13 2026 -
Ultragenyx Reports Positive Phase 3 Results for AAV8 Gene Therapy DTX301 in OTC Deficiency
Mar 12 2026 -
Johns Hopkins Scientists Develop Biodegradable Nanoparticles to Generate CAR-T Cells Directly in the Body
Mar 11 2026